Vertex Pharmaceuticals
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
56/100
Moderate Influence
$7.1M
Total Lobby Spend
4
Policy Issues
3
Lobbyists
1
Revolving Door
Vertex Pharmaceuticals reported $7.1 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Homeland Security
Centers for Medicare & Medicaid Services
US House of Representatives
White House
Small Business Administration
Dept of Interior
Dept of Housing & Urban Development
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Akin Gump LLP | PHAGOV | 3 | $449K |
| 2020 Apr-Jun | Cassidy & Associates LLP | GOVHCRPHA+1 | 2 | $342K |
| 2020 Jul-Sep | Akin Gump LLP | HCRPHAMED | 3 | $482K |
| 2020 Oct-Dec | K&L Gates LLP | MEDGOV | 1 | $510K |
| 2021 Jan-Mar | Holland & Knight LLP | MEDPHA | 2 | $257K |
| 2021 Apr-Jun | Holland & Knight LLP | HCR | 1 | $247K |
| 2021 Jul-Sep | Holland & Knight LLP | MEDGOVHCR+1 | 1 | $249K |
| 2021 Oct-Dec | Squire Patton Boggs LLP | GOV | 3 | $262K |